Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 35, 2022 - Issue 25
Submit an article Journal homepage
428
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Pharmacological treatment in pregnant women with moderate symptoms of coronavirus disease 2019 (COVID-19) pneumonia

Sebastian Nasrallaha Department of Obstetrics and Gynecology, INOVA Health System, Falls Church, VA, USAView further author information
,
Anh Q. Nguyena Department of Obstetrics and Gynecology, INOVA Health System, Falls Church, VA, USAView further author information
,
Laura Hitchingsb The Prenatal Pediatrics Institute, Children's National Hospital, Washington, DC, USAView further author information
,
Jenny Q. Wanga Department of Obstetrics and Gynecology, INOVA Health System, Falls Church, VA, USAView further author information
,
Sara Hamadea Department of Obstetrics and Gynecology, INOVA Health System, Falls Church, VA, USAView further author information
,
G. Larry Maxwella Department of Obstetrics and Gynecology, INOVA Health System, Falls Church, VA, USAView further author information
,
Alfred Khourya Department of Obstetrics and Gynecology, INOVA Health System, Falls Church, VA, USA;c Perinatal Associates of Northern Virginia, Fairfax, VA, USAView further author information
&
Luis M. Gomeza Department of Obstetrics and Gynecology, INOVA Health System, Falls Church, VA, USA;c Perinatal Associates of Northern Virginia, Fairfax, VA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8924-6386View further author information
ORCID Icon show all
Pages 5970-5977 | Received 11 Dec 2020, Accepted 10 Mar 2021, Published online: 26 Mar 2021

References

  • Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020;99(7):823–829.
  • Ellington S, Strid P, Tong VT, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status – United States, January 22–June 7, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(25):769–775.
  • Burwick RM, Yawetz S, Stephenson KE, et al. Compassionate use of remdesivir in pregnant women with severe Covid-19. Clin Infect Dis. 2020 Oct 8:ciaa1466. DOI:10.1093/cid/ciaa1466. Epub ahead of print. PMID: 33031500.
  • Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459–2468.
  • Beigel JH, Tomashek KM, Dodd LE, et al.; ACTT-1 Study Group Members. Remdesivir for the treatment of Covid-19 – final report. N Engl J Med. 2020;383(19):1813–1826.
  • Goldman JD, Lye DCB, Hui DS, et al.; GS-US-540-5773 Investigators. Remdesivir for 5 or 10 days in patients with severe Covid-19. N Engl J Med. 2020;383(19):1827–1837.
  • Horby P, Lim WS, Emberson JR, et al.; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19 – preliminary report. N Engl J Med. 2021;384(8):693–704.
  • Chen P, Nirula A, Heller B, et al. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with COVID-19. N Engl J Med. 2021;384(3):229–237. https://www.ncbi.nlm.nih.gov/pubmed/33113295
  • McCoy JA, Short WR, Srinivas SK, et al. Compassionate use of remdesivir for treatment of severe coronavirus disease 2019 in pregnant women at a United States academic center. Am J Obstet Gynecol. 2020;2(3):100164.
  • Naqvi M, Zakowski P, Glucksman L, et al. Tocilizumab and remdesivir in a pregnant patient with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2020;136(5):1025–1029.
  • Anderson J, Schauer J, Bryant S, et al. The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: a case report. Case Rep Womens Health. 2020;27:e00221.
  • Maldarelli GA, Savage M, Mazur S, et al. Remdesivir treatment for severe COVID-19 in third-trimester pregnancy: case report and management discussion. Open Forum Infect Dis. 2020;7(9):ofaa345.
  • Society for Maternal-Fetal Medicine. Management considerations for pregnant patients with COVID-19, 6.16.2020. Available from: https://s3.amazonaws.com/cdn.smfm.org/media/2401/SMFM_COVID_Management_of_COVID_pos_preg_patients_6-16-20._PDF.pdf. Accessed 02 February 2021.
  • COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available from: https://www.covid19treatmentguidelines.nih.gov/. Accessed 02 February 2021.
  • Magann EF, Doherty DA, Field K, et al. Biophysical profile with amniotic fluid volume assessments. Obstet Gynecol. 2004;104(1):5–10.
  • Sterne JAC, Murthy S, Diaz JV, et al.; WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020;324(13):1330–1341.
  • Agostini ML, Andres EL, Sims AC, et al. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio. 2018;9(2):e00221–18.
  • Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;382(24):2327–2336.
  • Spinner CD, Gottlieb RL, Criner GJ, et al.; GS-US-540-5774 Investigators. GS-US-540-5774 Investigators. Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial. JAMA. 2020;324(11):1048–1057.
  • Mulangu S, Dodd LE, Davey RT, Jr, et al.; PALM Consortium Study Team. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med. 2019;381(24):2293–2303.
  • Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428–430.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.